• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ZSTK

    ZeroStack Corp.

    Subscribe to $ZSTK
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2021

    Exchange: NASDAQ

    Recent Analyst Ratings for ZeroStack Corp.

    DatePrice TargetRatingAnalyst
    See more ratings

    ZeroStack Corp. SEC Filings

    View All

    ZeroStack Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - ZeroStack Corp. (0001790169) (Filer)

    3/31/26 5:02:17 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by ZeroStack Corp.

    10-K - ZeroStack Corp. (0001790169) (Filer)

    2/27/26 4:14:39 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZeroStack Corp. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nasdaq-Listed ZeroStack Corp. Makes $107 Million Institutional Commitment To Increase Strategic Position in 0G Token Ecosystem

    San Francisco, CA, April 02, 2026 (GLOBE NEWSWIRE) -- Zero Gravity Labs ("0G"), the modular AI chain powering the decentralized AI operating system, today announced that Nasdaq-listed ZeroStack Corp. (NASDAQ:ZSTK) has entered into definitive agreements for a $107 million financing transaction anchored by $0G Tokens. Upon closing, ZeroStack will hold approximately 21% of the total 0G token supply, establishing one of the largest institutional positions in any decentralized AI protocol. ZeroStack Corp. (NASDAQ:ZSTK) commits $107M to acquire 21% of total 0G token supply in the largest public market bet on decentralized AI infrastructure. The transaction represents a major milestone

    4/2/26 6:00:00 AM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZeroStack Announces $107 Million Cryptocurrency Financing, Elimination of Convertible Note and Plan to Redomicile to Texas

    Toronto, Ontario--(Newsfile Corp. - March 31, 2026) - Zerostack Corp. (NASDAQ:ZSTK) ("ZeroStack" or the "Company"), an artificial intelligence ("AI") focused asset management company, today announced that it has entered into definitive agreements for a private $107 million cryptocurrency financing transaction (the "Financing") that will significantly expand its digital asset holdings, strengthen its balance sheet, and position the Company for long-term growth in decentralized AI.Investors in the Financing contributed an aggregate of 142,232,948 native tokens of the Zero Gravity (0G) blockchain (the "0G Tokens") to Texas Blocker Corp., a Texas corporation formed by ZeroStack to facilitate the

    3/31/26 5:01:00 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZeroStack Corp. Reports 3.2 Million 0G Tokens Earned in Staking Rewards at 22% APY

    Toronto, Ontario--(Newsfile Corp. - March 5, 2026) - ZeroStack Corp. (NASDAQ:ZSTK) (the "Company" or "ZeroStack"), the first Nasdaq-listed, AI-focused asset management company, today announced that it has earned, in staking rewards (the "Staking Rewards"), 3.2 million 0G tokens (the native asset of the 0G decentralized artificial intelligence ("AI") operating system applications (each, a "0G Token" and, together, the "0G Tokens")) from its holdings of 0G Tokens since staking activities commenced on January 21, 2026, reflecting a current annual percentage yield ("APY") of approximately 22%. The U.S.-dollar equivalent is approximately $2.2 million for the period between January 21, 2026 and Ma

    3/5/26 8:00:00 AM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZeroStack Corp. Secures $6.5 Million Order from Major Pharmaceutical Company to Support Distribution in Germany

    Order to be Fulfilled Through German Subsidiary Phatebo GmbH, Reinforcing Company's Core Pharmaceutical Distribution PlatformToronto, Ontario--(Newsfile Corp. - March 4, 2026) - ZeroStack Corp. (NASDAQ:ZSTK) (the "Company" or "ZeroStack"), the first Nasdaq-listed, AI-focused asset management company, today announced that it has secured a $6.5 million order for the distribution in Germany. The order will be fulfilled through the Company's wholly owned German subsidiary, Phatebo GmbH ("Phatebo").Phatebo is a pharmaceutical distributor in Europe and has served as a portfolio company of ZeroStack's operations for the past five years. In connection with the Company's integration plan, Phatebo is

    3/4/26 9:29:00 AM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZeroStack Corp. Reports First One Million in 0G Token Staking Rewards at 21% APY

    Toronto, Ontario--(Newsfile Corp. - February 3, 2026) - ZeroStack Corp. (NASDAQ:ZSTK) (the "Company"), the first Nasdaq-listed, AI-focused asset management company, today announced that it has earned, in staking rewards (the "Staking Rewards"), its first one million in 0G tokens (the native asset of the 0G decentralized artificial intelligence ("AI") operating system applications (each, a "0G Token" and, together, the "0G Tokens")) from its holdings of 0G Tokens since staking activities commenced on January 21, 2026, reflecting a current annual percentage yield ("APY") of approximately 21%. The U.S.-dollar equivalent is approximately $840,000 for the period between January 21, 2026 and Febru

    2/3/26 8:00:00 AM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZeroStack Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Heinrich Michael

    4 - ZeroStack Corp. (0001790169) (Issuer)

    4/2/26 8:05:02 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care